Home › Funds › Eagle Health Investments LP › IMCR
Eagle Health Investments LP position in IMCR
IMMUNOCORE HLDGS PLC · Health Care
Eagle Health Investments LP reported holding 46,300 shares of IMCR (IMMUNOCORE HLDGS PLC) in its Q3 2026 13F filing — a position valued at US$1.4M, representing 0.25% of its reported portfolio and ranking #22 among its reported holdings. Eagle Health Investments LP has disclosed IMCR holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Eagle Health Investments LP's IMCR position evolved
Eagle Health Investments LP first disclosed a stake in IMCR in Q4 2023 at 46,300 shares (US$3.2M). Across 12 filings, Eagle Health Investments LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 46,300 shares valued at US$1.4M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 46.30K | $3.16M | New |
| Q1 2024 | 46.30K | $3.01M | Hold |
| Q2 2024 | 46.30K | $1.57M | Hold |
| Q3 2024 | 46.30K | $1.44M | Hold |
| Q4 2024 | 46.30K | $1.37M | Hold |
| Q1 2025 | 46.30K | $1.37M | Hold |
| Q2 2025 | 46.30K | $1.45M | Hold |
| Q3 2025 | 46.30K | $1.68M | Hold |
| Q4 2025 | 46.30K | $1.61M | Hold |
| Q1 2026 | 46.30K | $1.40M | Hold |
| Q2 2026 | 46.30K | $1.47M | Hold |
| Q3 2026 | 46.30K | $1.40M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMCR and 13F data
IMCR (IMMUNOCORE HLDGS PLC) is a Health Care company. 29 other funds we track also report a position in IMCR — the largest reported positions include RTW INVESTMENTS, LP (US$154.6M), Bellevue Group AG (US$88.5M), TANG CAPITAL MANAGEMENT LLC (US$84.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMCR
- RTW INVESTMENTS, LP 4.87M sh · $154.62M · Q2 2026
- Bellevue Group AG 2.79M sh · $88.53M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 2.65M sh · $84.12M · Q2 2026
- Vestal Point Capital, LP 1.80M sh · $57.15M · Q2 2026
- ARMISTICE CAPITAL, LLC 1.43M sh · $45.34M · Q2 2026
- Caligan Partners LP 1.38M sh · $43.86M · Q2 2026
- Kynam Capital Management, LP 1.38M sh · $43.66M · Q2 2026
- BVF INC/IL 1.29M sh · $41.10M · Q2 2026
- Trails Edge Capital Partners, LP 1.06M sh · $33.76M · Q2 2026
- Logos Global Management LP 600.00K sh · $19.05M · Q2 2026
- Frazier Life Sciences Management, L.P. 484.78K sh · $15.39M · Q2 2026
More on Eagle Health Investments LP
FAQ
How long has Eagle Health Investments LP held IMCR?
Eagle Health Investments LP has disclosed IMCR holdings in 12 of the last 12 reported quarters, going back to Q4 2023.
What is Eagle Health Investments LP's current position in IMCR?
As of Q3 2026, Eagle Health Investments LP holds 46.30K shares of IMCR (IMMUNOCORE HLDGS PLC), valued at $1.40M, representing 0.25% of its reported portfolio and ranking #22.
Has Eagle Health Investments LP been buying or selling IMCR?
In the latest 13F filing (Q3 2026), Eagle Health Investments LP held unchanged its position in IMCR.
Which other funds hold IMCR?
Other major institutional holders of IMCR include RTW INVESTMENTS, LP, Bellevue Group AG, TANG CAPITAL MANAGEMENT LLC, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.